JP2015505359A - 乳がん検出のための吸収紙及びその使用 - Google Patents

乳がん検出のための吸収紙及びその使用 Download PDF

Info

Publication number
JP2015505359A
JP2015505359A JP2014538957A JP2014538957A JP2015505359A JP 2015505359 A JP2015505359 A JP 2015505359A JP 2014538957 A JP2014538957 A JP 2014538957A JP 2014538957 A JP2014538957 A JP 2014538957A JP 2015505359 A JP2015505359 A JP 2015505359A
Authority
JP
Japan
Prior art keywords
absorbent paper
nipple aspirate
cells
sample
aspirate fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014538957A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015505359A5 (enExample
Inventor
クエイ，スティーブン，シー．
チェン，シュ−チー
Original Assignee
アトッサ ジェネティクス，インク．
アトッサ ジェネティクス，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アトッサ ジェネティクス，インク．, アトッサ ジェネティクス，インク． filed Critical アトッサ ジェネティクス，インク．
Publication of JP2015505359A publication Critical patent/JP2015505359A/ja
Publication of JP2015505359A5 publication Critical patent/JP2015505359A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0041—Detection of breast cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/683—Total protein determination, e.g. albumin in urine involving metal ions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/683—Total protein determination, e.g. albumin in urine involving metal ions
    • G01N33/6836—Silver staining

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2014538957A 2011-10-24 2012-10-24 乳がん検出のための吸収紙及びその使用 Pending JP2015505359A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161550855P 2011-10-24 2011-10-24
US61/550,855 2011-10-24
PCT/US2012/061733 WO2013063147A1 (en) 2011-10-24 2012-10-24 Absorbent paper and use thereof for breast cancer detection

Publications (2)

Publication Number Publication Date
JP2015505359A true JP2015505359A (ja) 2015-02-19
JP2015505359A5 JP2015505359A5 (enExample) 2015-12-17

Family

ID=48168446

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014538957A Pending JP2015505359A (ja) 2011-10-24 2012-10-24 乳がん検出のための吸収紙及びその使用

Country Status (6)

Country Link
US (3) US20130130310A1 (enExample)
EP (1) EP2771686A4 (enExample)
JP (1) JP2015505359A (enExample)
CN (1) CN104040339A (enExample)
CA (1) CA2853343A1 (enExample)
WO (1) WO2013063147A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013063147A1 (en) * 2011-10-24 2013-05-02 Atossa Genetics, Inc. Absorbent paper and use thereof for breast cancer detection
US20170145515A1 (en) * 2014-06-04 2017-05-25 Atossa Genetics Inc. Molecular mammography
CN106795555B (zh) * 2014-09-02 2021-04-02 谢达斌 聚合酶连锁反应的仪器与方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09149890A (ja) * 1995-09-27 1997-06-10 Hisamitsu Pharmaceut Co Inc 検査用貼付剤およびその検出装置並びに検査方法
JP2004524060A (ja) * 2000-11-13 2004-08-12 アトッサ ヘルスケア，インコーポレイティド 癌を含む胸部疾患を評価するために乳房分泌流体サンプルを採集、操作および処理する方法ならびに装置
JP2006519591A (ja) * 2003-01-15 2006-08-31 ロゼッタ インファーマティクス エルエルシー 乳癌患者の診断および予後

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786801A (en) * 1969-02-24 1974-01-22 Diagnostic Inc Method and apparatus for aiding in the detection of breast cancer
GB8415998D0 (en) 1984-06-22 1984-07-25 Janssen Pharmaceutica Nv Staining method
JPS6294170A (ja) * 1985-10-21 1987-04-30 ピジヨン株式会社 搾乳器
US5340746A (en) * 1993-01-08 1994-08-23 Minnesota Mining And Manufacturing Company Composite reactive articles for the determination of cyanide
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
US6328709B1 (en) * 1998-11-13 2001-12-11 Pro Duct Health, Inc. Devices and methods to identify ductal orifices during nipple aspiration
US6629936B2 (en) 2000-05-10 2003-10-07 Cytyc Health Corporation Method and kits for differentiating breast ducts for cancer risk status
US20020013539A1 (en) 2000-07-28 2002-01-31 David Hung Methods and devices for diagnosis of precancer and cancer in breast milk ducts
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
WO2003044485A2 (en) * 2001-11-20 2003-05-30 Proteex, Inc. Proteonomic methods for diagnosis and monitoring of breast cancer
US7128887B2 (en) 2003-05-29 2006-10-31 Specialty Minerals (Michigan) Inc. Platy precipitated calcium carbonate synthesis method
JP2008515871A (ja) 2004-10-07 2008-05-15 ナショナル インスティテュート オブ イミュノロジー 新規ガン関連抗体及び抗原並びにガンの診断におけるそれらの使用
WO2006062802A2 (en) * 2004-12-08 2006-06-15 Wang Paul C Device for non-surgical correction of congenital inverted nipples and/or collection of nipple aspirate fluid
WO2006128082A2 (en) * 2005-05-26 2006-11-30 The Johns Hopkins University Biomarkers for breast cancer
WO2008141318A1 (en) 2007-05-14 2008-11-20 Dr. Susan Love Research Foundation Device for determining risk of developing breast cancer and method thereof
WO2009059393A1 (en) * 2007-11-06 2009-05-14 University Health Network Method for the detection of breast cancer by determining alcam and/or bcam levels in a patient sample
CA2853351A1 (en) 2011-10-24 2013-05-02 Atossa Genetics, Inc. Method of breast cancer detection
WO2013063147A1 (en) 2011-10-24 2013-05-02 Atossa Genetics, Inc. Absorbent paper and use thereof for breast cancer detection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09149890A (ja) * 1995-09-27 1997-06-10 Hisamitsu Pharmaceut Co Inc 検査用貼付剤およびその検出装置並びに検査方法
JP2004524060A (ja) * 2000-11-13 2004-08-12 アトッサ ヘルスケア，インコーポレイティド 癌を含む胸部疾患を評価するために乳房分泌流体サンプルを採集、操作および処理する方法ならびに装置
JP2006519591A (ja) * 2003-01-15 2006-08-31 ロゼッタ インファーマティクス エルエルシー 乳癌患者の診断および予後

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KING E B ET AL.: "CELLULAR COMPOSITION OF THE NIPPLE ASPIRATE SPECIMEN OF BREAST FLUID I. THE BENIGN CELLS", AMERICAN JOURNAL OF CLINICAL PATHOLOGY, vol. 64, no. 6, JPN6016032380, 1 January 1975 (1975-01-01), pages 728 - 745, XP001056678, ISSN: 0003384914 *

Also Published As

Publication number Publication date
US20130130310A1 (en) 2013-05-23
US20150323537A1 (en) 2015-11-12
CN104040339A (zh) 2014-09-10
CA2853343A1 (en) 2013-05-02
EP2771686A4 (en) 2015-03-18
EP2771686A1 (en) 2014-09-03
WO2013063147A1 (en) 2013-05-02
US20140287430A1 (en) 2014-09-25
US9052318B2 (en) 2015-06-09

Similar Documents

Publication Publication Date Title
Stoy et al. Programmed death‐ligand 1 testing of lung cancer cytology specimens obtained with bronchoscopy
Palkovicova et al. Maternal amalgam dental fillings as the source of mercury exposure in developing fetus and newborn
Mantinieks et al. The effectiveness of decontamination procedures used in forensic hair analysis
Morales et al. Accuracy of self-reported tobacco use in newly diagnosed cancer patients
Vairo et al. Towards addressing the body electrolyte environment via sweat analysis: pilocarpine iontophoresis supports assessment of plasma potassium concentration
Lewis et al. The Northern Ireland Biobank: a cancer focused repository of science
Olms et al. Clinical comparison of liquid-based and conventional cytology of oral brush biopsies: a randomized controlled trial
Rodrigues-Peres et al. Aluminum concentrations in central and peripheral areas of malignant breast lesions do not differ from those in normal breast tissues
Woud et al. Direct detection of circulating donor-derived extracellular vesicles in kidney transplant recipients
Sims et al. Spirometry: an essential tool for screening, case-finding, and diagnosis of COPD
US9052318B2 (en) Absorbent paper and use thereof for breast cancer detection
Spugnini et al. Filling the gap between histology and cytology: description of an innovative technology (Cytomatrix) to increase the diagnostic effectiveness of fine needle aspirates data
Zhao et al. Effects of an Omaha system-based continuing nursing program on nutritional status in patients undergoing peritoneal dialysis: a randomized controlled trial
Nemes-Baran et al. Quantification of microglial contact and engulfment of oligodendrocyte progenitor cells in the rodent brain
Rahman et al. Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung
JP2015501429A (ja) 乳癌検出の方法
JP2017015711A (ja) 血液分析方法及び血液検査キット
JP2017012129A (ja) 血液分析方法及び血液検査キット
Tasaki et al. Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients
Urzi et al. Extracellular vesicles in uveal melanoma-Biological roles and diagnostic value
Foschini et al. Non-diagnostic
Kim et al. Ability and accuracy of the smartphone-based OVIEW-M® sperm test: Useful tool in the era of Covid-19
JP2015505359A5 (enExample)
CN105929168A (zh) 乳腺癌肿瘤标志物ca153的双阈值检测试纸
Archer et al. Relationship between prenatal lead exposure and infant blood lead levels

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151023

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151023

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160819

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160824

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170315